{"version":"1.0","provider_name":"VienaPaskola.LT","provider_url":"https:\/\/vienapaskola.lt","author_name":"admin","author_url":"https:\/\/vienapaskola.lt\/index.php\/author\/admin\/","title":"\u201eBiotech Startup Verigraft\u201c u\u017esitikrina 1,2 mln - VienaPaskola.LT","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"FWTR5GN3GX\"><a href=\"https:\/\/vienapaskola.lt\/index.php\/2025\/02\/15\/biotech-startup-verigraft-uzsitikrina-12-mln\/\">\u201eBiotech Startup Verigraft\u201c u\u017esitikrina 1,2 mln<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/vienapaskola.lt\/index.php\/2025\/02\/15\/biotech-startup-verigraft-uzsitikrina-12-mln\/embed\/#?secret=FWTR5GN3GX\" width=\"600\" height=\"338\" title=\"&#8220;\u201eBiotech Startup Verigraft\u201c u\u017esitikrina 1,2 mln&#8221; &#8212; VienaPaskola.LT\" data-secret=\"FWTR5GN3GX\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/vienapaskola.lt\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/vienapaskola.lt\/wp-content\/uploads\/2025\/02\/\u201eBiotech-Startup-Verigraft-uzsitikrina-12-mln-768x452.png","thumbnail_width":600,"thumbnail_height":353,"description":"Geteborge \u012fsik\u016brusi biotechnologij\u0173 \u012fmon\u0117 Verigraftas Buvo suteikta 1,2 mln. \u0160ia iniciatyva siekiama i\u0161spr\u0119sti reik\u0161mingus dabartin\u0117s transplantato technologijos i\u0161\u0161\u016bkius, \u012fskaitant ribot\u0105 \u017emoni\u0173 tonizuot\u0173 med\u017eiag\u0173 prieinamum\u0105, prast\u0105 integracij\u0105 ir auk\u0161t\u0105 gedim\u0173 procent\u0105. Projekto s\u0117km\u0117 gal\u0117t\u0173 paruo\u0161ti keli\u0105 pradiniams klinikiniams tyrimams su \u017emon\u0117mis ir ateityje komercializavimui, o potencialus pritaikymas vir\u0161ija kraujagysli\u0173 transplantatas. \u201c\u0160i \u201eEurostars\u201c dotacija yra pagrindinis \u201eVerigraft\u201c [&hellip;]"}